Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron VariantBenzinga • 12/02/21
Week 48 MDA Breakout Stocks - December 2021: Short-Term Picks To Give You An EdgeSeeking Alpha • 11/28/21
US Government Agrees To Purchase GSK-Vir Biotech's COVID-19 Antibody Doses Worth $1BBenzinga • 11/17/21
The Wall Street Journal: U.S. government will buy more of GlaxoSmithKline and Vir's COVID antibody drugMarket Watch • 11/17/21